Policy

DeVos Demands Efficacy in Education Programs, Contrary to Personal Investments

May 30, 2017

INSIDE DEVOS’ PERSONAL INVESTMENTS: Last week Betsy DeVos testified in front of Congress regarding cuts to federal education programs, noting that limited funds meant the budget needed to “put an emphasis on the programs that were proven to help students” by cutting programs that did not show clear benefits. However, according to an article written by Ulrich Boser, a senior fellow at the Center for American Progress (a left-leaning think tank), and published by the Washington Post, DeVos’ efficacy considerations for education are at odds with her personal investments.

Boser notes in his article that DeVos and her husband have an investment valued between $5 and $25 million in a brain-training company called Neurocore. The company boasts, “Med-Free neurofeedback treatment for ADHD, anxiety, depression, overall brain balance and more.” After visiting the center and speaking with many scientific experts, Boser concludes that the science on brain-training is too inconclusive for companies to guarantee results. Calling Neurocore, “a Trump University for people with cognitive struggles,” Boser asserts that the company’s practices “hurt” the patients they are claiming to serve by offering them false hope in “weak science.” He follows this assertion by questioning why DeVos chose to invest in such a firm—a question DeVos did not offer Boser a response to.  

Policy

DeVos Demands Efficacy in Education Programs, Contrary to Personal Investments

May 30, 2017

INSIDE DEVOS’ PERSONAL INVESTMENTS: Last week Betsy DeVos testified in front of Congress regarding cuts to federal education programs, noting that limited funds meant the budget needed to “put an emphasis on the programs that were proven to help students” by cutting programs that did not show clear benefits. However, according to an article written by Ulrich Boser, a senior fellow at the Center for American Progress (a left-leaning think tank), and published by the Washington Post, DeVos’ efficacy considerations for education are at odds with her personal investments.

Boser notes in his article that DeVos and her husband have an investment valued between $5 and $25 million in a brain-training company called Neurocore. The company boasts, “Med-Free neurofeedback treatment for ADHD, anxiety, depression, overall brain balance and more.” After visiting the center and speaking with many scientific experts, Boser concludes that the science on brain-training is too inconclusive for companies to guarantee results. Calling Neurocore, “a Trump University for people with cognitive struggles,” Boser asserts that the company’s practices “hurt” the patients they are claiming to serve by offering them false hope in “weak science.” He follows this assertion by questioning why DeVos chose to invest in such a firm—a question DeVos did not offer Boser a response to.  

Next In Policy

Next in Policy

STAY UP TO DATE ON EDTECH
News, research, and opportunities - sent weekly.
STAY UP TO DATE ON EDTECH
News, research, and opportunities - sent weekly.